Based on Phase 2 trial data (Jastreboff et al., NEJM 2023), retatrutide's side effect profile appears broadly consistent with other GLP-1-based therapies, though the addition of glucagon receptor agonism introduces some distinct considerations
Los estudios muestran que, al suspender el tratamiento sin haber establecido cambios slidos de estilo de vida, es comn recuperar gran parte del peso perdido (efecto rebote fisiolgico)
They mimic a natural hormone that slows down gastric emptying, which means food stays in your stomach for a longer period
Clinical Research Notes
Semaglutide in Type 2 Diabetic Adult Patients GLP-1 Medications and At-Home Lab Testing With Everlywell Related Content The class of medications known as GLP1 drugs has been in the news lately.[1,2] GLP1s, or glucagon-like peptide-1 receptor agonists, are also called GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs.[3,4] There are several medications in the GLP1 drug class